Kiromic Biopharma, Inc.

Biological Products, (No Diagnostic Substances)·HOUSTON, TX

CEO

Bersani Pietro

CFO

Hungerford Brian

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2024	12/31/24	2/14/25	→
10-Q	Q3 2024	9/30/24	11/8/24	→
10-Q	Q2 2024	6/30/24	8/9/24	→
10-Q	Q1 2024	3/31/24	5/10/24	→
10-K/A	FY 2023	12/31/23	3/21/24	→
10-K	FY 2023	12/31/23	3/19/24	→
↓

Earnings Releases (8-K)

4 shown

Filed	Period
5/13/22	Q2 FY2022	→
4/8/22	Q1 FY2022	→
3/11/22	Q1 FY2022	→
8/13/21	Q3 FY2021	→

News (8-K)

76 shown

Filed	Type	Description
3/21/25	Other	Amendments to Articles of Incorporation or Bylaws	→
3/17/25	Other	Other Events	→
2/3/25	Agreement	Entry into a Material Definitive Agreement	→
2/3/25	Agreement	Entry into a Material Definitive Agreement	→
12/11/24	Agreement	Entry into a Material Definitive Agreement	→
11/4/24	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

30 shown

Filed	Form	Description
2/19/25	S-1/A	FORM S-1/A	→
1/17/25	S-1	S-1	→
5/20/24	ARS	ARS	→
8/15/23	S-8	S-8	→
6/29/23	S-1	S-1	→
5/25/23	424B3	424B3	→
↓

Filing History(252 filings)

TypeDateAccessionPeriodSize

8-K

Mar 21, 2025

0001437749-25-008671FORM 8-K

Mar 21, 2025

162.4 KB

8-K

Mar 17, 2025

0001437749-25-008047FORM 8-K

Mar 11, 2025

162.3 KB

S-1/A

Feb 19, 2025

0001437749-25-004407FORM S-1/A

—

10.6 MB

10-K

Feb 14, 2025

0001437749-25-004000FORM 10-K

Dec 31, 2024

8.1 MB

8-K/A

Feb 3, 2025

0001437749-25-002590FORM 8-K/A

Jan 28, 2025

347.9 KB

8-K

Feb 3, 2025

0001437749-25-002474FORM 8-K

Jan 28, 2025

343.1 KB

S-1

Jan 17, 2025

0001437749-25-001415FORM S-1

—

17.4 MB

8-K

Dec 11, 2024

0001437749-24-037243FORM 8-K

Dec 9, 2024

331.8 KB

10-Q

Nov 8, 2024

0001437749-24-034182FORM 10-Q

Sep 30, 2024

6.4 MB

SC 13G/A

Nov 4, 2024

0001104659-24-113995SC 13G/A

—

124.6 KB

8-K

Nov 4, 2024

0001437749-24-033147FORM 8-K

Nov 1, 2024

227.7 KB

8-K

Sep 30, 2024

0001437749-24-030260FORM 8-K

Sep 27, 2024

334.0 KB

Aug 26, 2024

0001437749-24-027784FORM 4

Aug 23, 2024

5.6 KB

Aug 21, 2024

0001437749-24-027492FORM 4

Aug 19, 2024

5.5 KB

Aug 14, 2024

0001437749-24-026863FORM 4

Aug 13, 2024

4.2 KB

10-Q

Aug 9, 2024

0001437749-24-025818FORM 10-Q

Jun 30, 2024

6.4 MB

8-K

Aug 5, 2024

0001437749-24-024658FORM 8-K

Aug 1, 2024

337.2 KB

8-K

Jul 10, 2024

0001104659-24-078698FORM 8-K

Jul 3, 2024

365.6 KB

8-K

Jun 28, 2024

0001558370-24-0096218-K

Jun 26, 2024

180.2 KB

8-K

Jun 27, 2024

0001558370-24-0095618-K

Jun 21, 2024

485.5 KB

Jun 13, 2024

0001104659-24-071382OWNERSHIP DOCUMENT

Jun 12, 2024

6.0 KB

Jun 13, 2024

0001104659-24-071297OWNERSHIP DOCUMENT

Jun 13, 2024

4.5 KB

Jun 12, 2024

0001104659-24-070884OWNERSHIP DOCUMENT

Jun 11, 2024

4.6 KB

Jun 12, 2024

0001104659-24-070883OWNERSHIP DOCUMENT

Jun 10, 2024

4.5 KB

Jun 12, 2024

0001104659-24-070881OWNERSHIP DOCUMENT

Jun 12, 2024

4.5 KB

25 filings shown

Filed	Form	Description
5/17/24	DEF 14A	DEF 14A	→
5/7/24	PRE 14A	PRE 14A	→
7/18/23	DEFA14A	DEFA14A	→
6/16/23	DEF 14A	DEF 14A	→
2/23/23	DEFA14A	DEFA14A	→
2/16/23	DEFA14A	DEFA14A	→
↓

Filed	Form	Description
4/10/24	RW	RW	→
11/20/23	25-NSE	25-NSE	→
5/19/23	EFFECT	EFFECT	→
8/19/22	RW	FORM RW	→
6/29/21	EFFECT	EFFECT	→
6/11/21	DRS	DRS	→
↓

Kiromic Biopharma, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(252 filings)

Proxies

Ownership

Other Filings